Cargando…

Novel Antibodies for the Simple and Efficient Enrichment of Native O-GlcNAc Modified Peptides

Antibodies against posttranslational modifications (PTMs) such as lysine acetylation, ubiquitin remnants, or phosphotyrosine have resulted in significant advances in our understanding of the fundamental roles of these PTMs in biology. However, the roles of a number of PTMs remain largely unexplored...

Descripción completa

Detalles Bibliográficos
Autores principales: Burt, Rajan A., Dejanovic, Borislav, Peckham, Hayley J., Lee, Kimberly A., Li, Xiang, Ounadjela, Johain R., Rao, Anjana, Malaker, Stacy A., Carr, Steven A., Myers, Samuel A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Biochemistry and Molecular Biology 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605273/
https://www.ncbi.nlm.nih.gov/pubmed/34678516
http://dx.doi.org/10.1016/j.mcpro.2021.100167
_version_ 1784602143235244032
author Burt, Rajan A.
Dejanovic, Borislav
Peckham, Hayley J.
Lee, Kimberly A.
Li, Xiang
Ounadjela, Johain R.
Rao, Anjana
Malaker, Stacy A.
Carr, Steven A.
Myers, Samuel A.
author_facet Burt, Rajan A.
Dejanovic, Borislav
Peckham, Hayley J.
Lee, Kimberly A.
Li, Xiang
Ounadjela, Johain R.
Rao, Anjana
Malaker, Stacy A.
Carr, Steven A.
Myers, Samuel A.
author_sort Burt, Rajan A.
collection PubMed
description Antibodies against posttranslational modifications (PTMs) such as lysine acetylation, ubiquitin remnants, or phosphotyrosine have resulted in significant advances in our understanding of the fundamental roles of these PTMs in biology. However, the roles of a number of PTMs remain largely unexplored due to the lack of robust enrichment reagents. The addition of N-acetylglucosamine to serine and threonine residues (O-GlcNAc) by the O-GlcNAc transferase (OGT) is a PTM implicated in numerous biological processes and disease states but with limited techniques for its study. Here, we evaluate a new mixture of anti-O-GlcNAc monoclonal antibodies for the immunoprecipitation of native O-GlcNAcylated peptides from cells and tissues. The anti-O-GlcNAc antibodies display good sensitivity and high specificity toward O-GlcNAc-modified peptides and do not recognize O-GalNAc or GlcNAc in extended glycans. Applying this antibody-based enrichment strategy to synaptosomes from mouse brain tissue samples, we identified over 1300 unique O-GlcNAc-modified peptides and over 1000 sites using just a fraction of sample preparation and instrument time required in other landmark investigations of O-GlcNAcylation. Our rapid and robust method greatly simplifies the analysis of O-GlcNAc signaling and will help to elucidate the role of this challenging PTM in health and disease.
format Online
Article
Text
id pubmed-8605273
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Society for Biochemistry and Molecular Biology
record_format MEDLINE/PubMed
spelling pubmed-86052732021-11-24 Novel Antibodies for the Simple and Efficient Enrichment of Native O-GlcNAc Modified Peptides Burt, Rajan A. Dejanovic, Borislav Peckham, Hayley J. Lee, Kimberly A. Li, Xiang Ounadjela, Johain R. Rao, Anjana Malaker, Stacy A. Carr, Steven A. Myers, Samuel A. Mol Cell Proteomics Technological Innovation and Resources Antibodies against posttranslational modifications (PTMs) such as lysine acetylation, ubiquitin remnants, or phosphotyrosine have resulted in significant advances in our understanding of the fundamental roles of these PTMs in biology. However, the roles of a number of PTMs remain largely unexplored due to the lack of robust enrichment reagents. The addition of N-acetylglucosamine to serine and threonine residues (O-GlcNAc) by the O-GlcNAc transferase (OGT) is a PTM implicated in numerous biological processes and disease states but with limited techniques for its study. Here, we evaluate a new mixture of anti-O-GlcNAc monoclonal antibodies for the immunoprecipitation of native O-GlcNAcylated peptides from cells and tissues. The anti-O-GlcNAc antibodies display good sensitivity and high specificity toward O-GlcNAc-modified peptides and do not recognize O-GalNAc or GlcNAc in extended glycans. Applying this antibody-based enrichment strategy to synaptosomes from mouse brain tissue samples, we identified over 1300 unique O-GlcNAc-modified peptides and over 1000 sites using just a fraction of sample preparation and instrument time required in other landmark investigations of O-GlcNAcylation. Our rapid and robust method greatly simplifies the analysis of O-GlcNAc signaling and will help to elucidate the role of this challenging PTM in health and disease. American Society for Biochemistry and Molecular Biology 2021-10-20 /pmc/articles/PMC8605273/ /pubmed/34678516 http://dx.doi.org/10.1016/j.mcpro.2021.100167 Text en © 2021 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Technological Innovation and Resources
Burt, Rajan A.
Dejanovic, Borislav
Peckham, Hayley J.
Lee, Kimberly A.
Li, Xiang
Ounadjela, Johain R.
Rao, Anjana
Malaker, Stacy A.
Carr, Steven A.
Myers, Samuel A.
Novel Antibodies for the Simple and Efficient Enrichment of Native O-GlcNAc Modified Peptides
title Novel Antibodies for the Simple and Efficient Enrichment of Native O-GlcNAc Modified Peptides
title_full Novel Antibodies for the Simple and Efficient Enrichment of Native O-GlcNAc Modified Peptides
title_fullStr Novel Antibodies for the Simple and Efficient Enrichment of Native O-GlcNAc Modified Peptides
title_full_unstemmed Novel Antibodies for the Simple and Efficient Enrichment of Native O-GlcNAc Modified Peptides
title_short Novel Antibodies for the Simple and Efficient Enrichment of Native O-GlcNAc Modified Peptides
title_sort novel antibodies for the simple and efficient enrichment of native o-glcnac modified peptides
topic Technological Innovation and Resources
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605273/
https://www.ncbi.nlm.nih.gov/pubmed/34678516
http://dx.doi.org/10.1016/j.mcpro.2021.100167
work_keys_str_mv AT burtrajana novelantibodiesforthesimpleandefficientenrichmentofnativeoglcnacmodifiedpeptides
AT dejanovicborislav novelantibodiesforthesimpleandefficientenrichmentofnativeoglcnacmodifiedpeptides
AT peckhamhayleyj novelantibodiesforthesimpleandefficientenrichmentofnativeoglcnacmodifiedpeptides
AT leekimberlya novelantibodiesforthesimpleandefficientenrichmentofnativeoglcnacmodifiedpeptides
AT lixiang novelantibodiesforthesimpleandefficientenrichmentofnativeoglcnacmodifiedpeptides
AT ounadjelajohainr novelantibodiesforthesimpleandefficientenrichmentofnativeoglcnacmodifiedpeptides
AT raoanjana novelantibodiesforthesimpleandefficientenrichmentofnativeoglcnacmodifiedpeptides
AT malakerstacya novelantibodiesforthesimpleandefficientenrichmentofnativeoglcnacmodifiedpeptides
AT carrstevena novelantibodiesforthesimpleandefficientenrichmentofnativeoglcnacmodifiedpeptides
AT myerssamuela novelantibodiesforthesimpleandefficientenrichmentofnativeoglcnacmodifiedpeptides